Gambling, Resorts & Casinos
Compare Stocks
2 / 10Stock Comparison
CDRO vs GENI
Revenue, margins, valuation, and 5-year total return — side by side.
Internet Content & Information
CDRO vs GENI — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | Gambling, Resorts & Casinos | Internet Content & Information |
| Market Cap | $423M | $1.17B |
| Revenue (TTM) | $201M | $669M |
| Net Income (TTM) | $4M | $-112M |
| Gross Margin | 90.6% | 22.9% |
| Operating Margin | 2.2% | -18.1% |
| Forward P/E | 26.1x | 52.4x |
| Total Debt | $4M | $30M |
| Cash & Equiv. | $50M | $281M |
CDRO vs GENI — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Codere Online Luxem… (CDRO) | 100 | 92.0 | -8.0% |
| Genius Sports Limit… (GENI) | 100 | 23.0 | -77.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CDRO vs GENI
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CDRO carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- beta 0.51
- -9.3% 10Y total return vs GENI's -52.4%
- Lower volatility, beta 0.51, Low D/E 13.7%, current ratio 1.37x
GENI is the clearest fit if your priority is growth exposure.
- Rev growth 31.0%, EPS growth -63.0%, 3Y rev CAGR 25.2%
- 31.0% revenue growth vs CDRO's 4.8%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 31.0% revenue growth vs CDRO's 4.8% | |
| Value | Lower P/E (26.1x vs 52.4x) | |
| Quality / Margins | 1.9% margin vs GENI's -16.7% | |
| Stability / Safety | Beta 0.51 vs GENI's 1.50 | |
| Dividends | Tie | Neither stock pays a meaningful dividend |
| Momentum (1Y) | +14.3% vs GENI's -53.1% | |
| Efficiency (ROA) | 5.3% ROA vs GENI's -11.1% |
CDRO vs GENI — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CDRO vs GENI — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
CDRO leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
GENI is the larger business by revenue, generating $669M annually — 3.3x CDRO's $201M. CDRO is the more profitable business, keeping 1.9% of every revenue dollar as net income compared to GENI's -16.7%. On growth, GENI holds the edge at +37.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $201M | $669M |
| EBITDAEarnings before interest/tax | $4M | -$50M |
| Net IncomeAfter-tax profit | $4M | -$112M |
| Free Cash FlowCash after capex | $4M | $37M |
| Gross MarginGross profit ÷ Revenue | +90.6% | +22.9% |
| Operating MarginEBIT ÷ Revenue | +2.2% | -18.1% |
| Net MarginNet income ÷ Revenue | +1.9% | -16.7% |
| FCF MarginFCF ÷ Revenue | +1.8% | +5.5% |
| Rev. Growth (YoY)Latest quarter vs prior year | +13.3% | +37.0% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.8% | +33.8% |
Valuation Metrics
GENI leads this category, winning 3 of 5 comparable metrics.
Valuation Metrics
| Metric | ||
|---|---|---|
| Market CapShares × price | $423M | $1.2B |
| Enterprise ValueMkt cap + debt − cash | $369M | $924M |
| Trailing P/EPrice ÷ TTM EPS | 263.51x | -10.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 26.08x | 52.42x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 49.20x | — |
| Price / SalesMarket cap ÷ Revenue | 1.71x | 1.75x |
| Price / BookPrice ÷ Book value/share | 12.64x | 1.68x |
| Price / FCFMarket cap ÷ FCF | 21.93x | 18.18x |
Profitability & Efficiency
CDRO leads this category, winning 5 of 7 comparable metrics.
Profitability & Efficiency
CDRO delivers a 18.1% return on equity — every $100 of shareholder capital generates $18 in annual profit, vs $-16 for GENI. GENI carries lower financial leverage with a 0.04x debt-to-equity ratio, signaling a more conservative balance sheet compared to CDRO's 0.14x. On the Piotroski fundamental quality scale (0–9), CDRO scores 5/9 vs GENI's 3/9, reflecting solid financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | +18.1% | -15.5% |
| ROA (TTM)Return on assets | +5.3% | -11.1% |
| ROICReturn on invested capital | — | -16.6% |
| ROCEReturn on capital employed | +18.8% | -15.3% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 |
| Debt / EquityFinancial leverage | 0.14x | 0.04x |
| Net DebtTotal debt minus cash | -$46M | -$250M |
| Cash & Equiv.Liquid assets | $50M | $281M |
| Total DebtShort + long-term debt | $4M | $30M |
| Interest CoverageEBIT ÷ Interest expense | — | -136.57x |
Total Returns (Dividends Reinvested)
CDRO leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CDRO five years ago would be worth $9,299 today (with dividends reinvested), compared to $2,536 for GENI. Over the past 12 months, CDRO leads with a +14.3% total return vs GENI's -53.1%. The 3-year compound annual growth rate (CAGR) favors CDRO at 51.0% vs GENI's 5.5% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +15.4% | -55.8% |
| 1-Year ReturnPast 12 months | +14.3% | -53.1% |
| 3-Year ReturnCumulative with dividends | +244.1% | +17.4% |
| 5-Year ReturnCumulative with dividends | -7.0% | -74.6% |
| 10-Year ReturnCumulative with dividends | -9.3% | -52.4% |
| CAGR (3Y)Annualised 3-year return | +51.0% | +5.5% |
Risk & Volatility
CDRO leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CDRO is the less volatile stock with a 0.51 beta — it tends to amplify market swings less than GENI's 1.50 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CDRO currently trades 95.6% from its 52-week high vs GENI's 34.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.51x | 1.50x |
| 52-Week HighHighest price in past year | $9.72 | $13.73 |
| 52-Week LowLowest price in past year | $5.18 | $3.83 |
| % of 52W HighCurrent price vs 52-week peak | +95.6% | +34.7% |
| RSI (14)Momentum oscillator 0–100 | 55.3 | 45.3 |
| Avg Volume (50D)Average daily shares traded | 14K | 5.6M |
Analyst Outlook
Insufficient data to determine a leader in this category.
Analyst Outlook
Wall Street rates CDRO as "Hold" and GENI as "Buy". Consensus price targets imply 153.9% upside for GENI (target: $12) vs -8.5% for CDRO (target: $9).
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $8.50 | $12.10 |
| # AnalystsCovering analysts | 1 | 19 |
| Dividend YieldAnnual dividend ÷ price | — | — |
| Dividend StreakConsecutive years of raises | — | 1 |
| Dividend / ShareAnnual DPS | — | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.7% | 0.0% |
CDRO leads in 4 of 6 categories (Income & Cash Flow, Profitability & Efficiency). GENI leads in 1 (Valuation Metrics).
CDRO vs GENI: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CDRO or GENI a better buy right now?
For growth investors, Genius Sports Limited (GENI) is the stronger pick with 31.
0% revenue growth year-over-year, versus 4. 8% for Codere Online Luxembourg, S. A. (CDRO). Codere Online Luxembourg, S. A. (CDRO) offers the better valuation at 263. 5x trailing P/E (26. 1x forward), making it the more compelling value choice. Analysts rate Genius Sports Limited (GENI) a "Buy" — based on 19 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CDRO or GENI?
On forward P/E, Codere Online Luxembourg, S.
A. is actually cheaper at 26. 1x.
03Which is the better long-term investment — CDRO or GENI?
Over the past 5 years, Codere Online Luxembourg, S.
A. (CDRO) delivered a total return of -7. 0%, compared to -74. 6% for Genius Sports Limited (GENI). Over 10 years, the gap is even starker: CDRO returned -9. 3% versus GENI's -52. 4%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CDRO or GENI?
By beta (market sensitivity over 5 years), Codere Online Luxembourg, S.
A. (CDRO) is the lower-risk stock at 0. 51β versus Genius Sports Limited's 1. 50β — meaning GENI is approximately 192% more volatile than CDRO relative to the S&P 500. On balance sheet safety, Genius Sports Limited (GENI) carries a lower debt/equity ratio of 4% versus 14% for Codere Online Luxembourg, S. A. — giving it more financial flexibility in a downturn.
05Which is growing faster — CDRO or GENI?
By revenue growth (latest reported year), Genius Sports Limited (GENI) is pulling ahead at 31.
0% versus 4. 8% for Codere Online Luxembourg, S. A. (CDRO). On earnings-per-share growth, the picture is similar: Codere Online Luxembourg, S. A. grew EPS -62. 5% year-over-year, compared to -63. 0% for Genius Sports Limited. Over a 3-year CAGR, GENI leads at 25. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CDRO or GENI?
Codere Online Luxembourg, S.
A. (CDRO) is the more profitable company, earning 0. 6% net margin versus -16. 7% for Genius Sports Limited — meaning it keeps 0. 6% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CDRO leads at 2. 7% versus -15. 6% for GENI. At the gross margin level — before operating expenses — CDRO leads at 96. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CDRO or GENI more undervalued right now?
On forward earnings alone, Codere Online Luxembourg, S.
A. (CDRO) trades at 26. 1x forward P/E versus 52. 4x for Genius Sports Limited — 26. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for GENI: 153. 9% to $12. 10.
08Which pays a better dividend — CDRO or GENI?
None of the stocks in this comparison currently pay a material dividend.
All are effectively zero-yield and should be held for capital appreciation rather than income.
09Is CDRO or GENI better for a retirement portfolio?
For long-horizon retirement investors, Codere Online Luxembourg, S.
A. (CDRO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 51)). Genius Sports Limited (GENI) carries a higher beta of 1. 50 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (CDRO: -9. 3%, GENI: -52. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CDRO and GENI?
These companies operate in different sectors (CDRO (Consumer Cyclical) and GENI (Communication Services)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: CDRO is a small-cap quality compounder stock; GENI is a small-cap high-growth stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
- Sector: Communication Services
- Market Cap > $100B
- Revenue Growth > 18%
- Gross Margin > 13%
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.